Crossmark

A direct comparison of classical oral Navelbine vs metronomic Navelbine in metastatic breast cancer: results from the Danish Breast Cancer Group’s (DBCG) NAME-trial

Crossref DOI link: https://doi.org/10.1007/s10549-025-07777-5

Published Online: 2025-07-11

Published Print: 2025-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Brems-Eskildsen, Anne Sofie

Kenholm, Julia

Brixen, Annette Torbøl

Rønlev, Jeanette Dupont

Stenbygaard, Lars

Danø, Hella

Grunnet, Mie

Jakobsen, Erik Hugger

Neimann, Jeppe

Langkjer, Sven Tyge

Geisler, Jürgen
Funding

Funding for this research was provided by:

Aarhus University Hospital
License Information

Text and Data Mining valid from 2025-07-11

Version of Record valid from 2025-07-11
More Information

Article History

Received: 27 January 2025

Accepted: 27 June 2025

First Online: 11 July 2025

Declarations

:

: The authors declare no competing interests.

: We declare this study was performed in line with the principles of the Declaration of Helsinki and Human Etics Approval was granted by the Ethics Committee 14-6-2017 with approval number: 1-10-72-305-16 with the project name: NAME: Direct Comparison of oral navelbine given either classic or metronomic in metastatic breast cancer.

: Written informed Consent to Participate was obtained from all individual participants included in the study.

Document is current

Any future updates will be listed below